Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors

Polymyalgia rheumatica (PMR) and PMR-like syndromes are among the most frequent rheumatologic immuno-related adverse events (IRAEs) induced by cancer immunotherapy with “checkpoint inhibitors” (ICIs). Our short communication addresses two key methodological issues laid bare by published literature :...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ciro Manzo, Marco Isetta
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2021
Materias:
R
Acceso en línea:https://doaj.org/article/0f269c23c9a44c99b20348f186bd961d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!